Clinical Trial Update: MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for MAXOMAT evaluating treatment of severe early onset intrauterine growth retardation in pre-pubertal children; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Retardation

Drugs mentioned

• MAXOMAT

Snippet

Sponsor: Sanofi | Conditions: Fetal Growth Retardation | Phase 3 | Status: COMPLETED